Companies / United Kingdom
Renovo Plans US$243mn IPO
March 2006 | Company Finance AlertUK pharmaceutical company Renovo is planning an STG139mn (US$243mn) initial public offering (IPO) of its stock. Proceeds of STG40mn (US$70mn) from the offering will be used to further the development of Juvista and Zesteem for the reduction of scarring and the acceleration of healing following surgery,
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
